ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:09 AM

ANIP 55.00 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 55.35 Closing the day 09:44 at 55.00 +1.05 +1.95% With a day low of 54.01 and a total volume of 45,608.

ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/

ANIP ANI Pharmaceuticals Inc Recent Headline News

Puma Biotechnology Slumps: PBYI Tumbles 9.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 23 mins ago
Puma Biotechnology has been witnessing a negative trend in its current year loss estimates and its share price falling for past few weeks
ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24), PBYI: 219.00 (+2.78)

Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:13PM CST
On Nov 14, 2014, Zacks Investment Research upgraded Affymetrix Inc. (AFFX) to a Zacks Rank #1 (Strong Buy).
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)

Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:34AM CST
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 55.62 (+1.67), ICPT: 159.01 (-3.57), AMAG: 34.86 (+0.86), AFFX: 9.47 (-0.24)

Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:26AM CST
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 55.62 (+1.67)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 55.62 (+1.67), SCMP: 11.60 (+0.30)

Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 55.62 (+1.67)

Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 305.86 (+0.43), ANIP: 55.62 (+1.67), CLDX: 17.27 (+3.11), AMAG: 34.86 (+0.86)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.59 (+0.13), ANIP: 55.62 (+1.67), ACGL: 56.87 (-0.43), ACCO: 8.96 (-0.03), FLWS: 8.98 (-0.01)

ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 55.62 (+1.67)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 23.53 (-0.45), HBNK: 20.10 (+0.32), ASMI: 41.46 (+0.20), RRGB: 68.08 (-0.43), SAPE: 24.69 (+0.01), PLUG: 3.78 (+0.06), ANIP: 55.62 (+1.67), ODP: 6.57 (-0.22), MTEX: 21.41 (+1.10), JAXB: 11.75 (-0.15), ALQA: 5.07 (+0.02), YRCW: 23.96 (+0.23)

Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST

FRM: 6.14 (+0.06), NEO: 4.66 (-0.02), AU: 9.33 (-0.23), FNHC: 24.82 (+0.09), AMS: 2.53 (-0.19), NYMX: 0.58 (+0.03), AMDA: 1.39 (+0.17), CVD: 100.36 (+0.06), GBIM: 6.50 (+0.20), RCAP: 12.00 (-0.09), KBIO: 2.02 (-0.08), COOL: 0.85 (-0.05), SAPE: 24.69 (+0.01), XTLB: 2.58 (+0.13), GERN: 2.93 (+0.17), ANIP: 55.62 (+1.67), BBLU: 1.26 (-0.04), NXTD: 2.29 (-0.02), AP: 18.80 (-0.08), ALQA: 5.07 (+0.02)

ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST

ANIP: 55.62 (+1.67)

ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 55.62 (+1.67)

ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST

ANIP: 55.62 (+1.67)

ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"

(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 55.62 (+1.67)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST

ACW: 4.74 (-0.07), SYY: 38.78 (+0.20), L: 42.52 (-0.26), EEP: 37.56 (+0.22), SNH: 22.24 (+0.06), INN: 11.52 (-0.02), ITG: 19.70 (+0.19), NSP: 33.00 (+0.02), S: 5.03 (-0.02), ALE: 49.93 (+0.10), GVA: 36.44 (+0.17), MCY: 53.95 (-0.10), ARNA: 4.58 (+0.05), CHD: 73.44 (-0.09), ARE: 82.62 (+0.30), USAK: 18.44 (-0.01), BWP: 16.83 (-0.12), KRG: 26.17 (-0.03), CYOU: 23.50 (-0.37), MNKD: 6.08 (-0.08), HNT: 50.55 (+0.75), AMH: 17.24 (-0.03), ARCB: 42.78 (+0.17), ANIP: 55.62 (+1.67), AMG: 195.42 (-1.52), HAE: 37.12 (-0.01), SOHU: 50.14 (-0.82), CNA: 38.99 (-0.13)

ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 107.70 (+0.80), MACK: 8.63 (+0.15), ANIP: 55.62 (+1.67), ILMN: 180.99 (+0.49)

ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT

ANIP: 55.62 (+1.67)

5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 55.62 (+1.67), KTOS: 5.38 (-0.02), BLOX: 17.06 (+0.20), CSLT: 11.42 (-0.44), FPRX: 15.28 (+0.09)

ANI Pharmaceuticals Inc. (ANIP) Stock Research Links

ANIP Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bernard Lancaster Steps Up as Mammoth's New President

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Stent or Meds? Long-Term Study Questions Benefits

The Long Game in Cardiology There's this long-standing debate in cardiology about whether sticking a metal stent in an artery actually prevents heart attacks or just looks impressive. Well, after chewing on 25 years of data from the COURAGE trial, CU Anschutz researchers led by Dr. Neel Butala have thrown a curveball — these stents might not be as life-saving as many...

Finding the Right Auto Insurance: What to Consider

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Diwali Celebration in Chicago Honors Indian Community

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Sports Clock Radio: A Game Time Enthusiast's Dream

A New Gadget for the Diehard Fan Fanatics, gather 'round. There's an innovation rolling out that's looking to marry the good old alarm clock radio with the rush of game day fever! Over in Pittsburgh, an inventor's cooking up something that every loyal sports fan might soon find irresistible—a Sports Clock Radio, bringing the stadium experience to your living room or...

ManuTech Center Set to Revolutionize Manufacturing Hub

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

GTEC Faces Nasdaq Bid Price Compliance Challenge

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Cuisine.K Brings Korean Seafood to Seattle Spotlight

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...